Carlos R. Becerra, MD

R. Matthew Carroll, M.D., is a board-certified hematologist/oncologist for the Hoag Family Cancer Institute. With more than 18 years of experience, Dr. Carroll treats a broad range of disorders with a special interest in breast cancer and hematologic malignancies. Dr. Carroll practices in the Hoag Family Cancer Center’s Newport Beach location. Dr. Carroll attended Drexel University College of Medicine in Philadelphia. He completed an internship in internal medicine at University of Utah Hospital and his residency in internal medicine and fellowship in hematology/oncology at Harbor – UCLA Medical Center. Dr. Carroll is certified by the American Board of Internal Medicine in Hematology and Medical Oncology. During his tenure at Hoag, he has served on the Cancer Committee, on the Pharmacy and Therapeutics Committee and as Chairman of his department. Dr. Carroll is uncompromising in his dedication to the well-being of his patients. In his spare time, Dr. Carroll enjoys spending time with his wife and three children, traveling and playing bass guitar in an alternative rock band.

Dr. Benjamin enjoys working alongside a team of experts in the cancer field to provide high-quality, personal care to patients as a board-certified medical oncologist at Hoag Family Cancer Center. His practice focuses on genitourinary cancers, including prostate, bladder, kidney and testicular cancer. Dr. Benjamin provides a caring environment for his patients, where he works alongside patients on their cancer journey to determine the best treatment plans for their individual diagnoses. Through his involvement in cancer research, Dr. Benjamin is actively working to identify therapies that improve the lives of patients with genitourinary cancers through clinical trials at Hoag. Dr. Benjamin has co-authored numerous publications in leading medical journals, including JAMA Oncology, The Lancet Oncology and Nature Reviews Urology. He has presented his research at several national and international conferences. He received the 2022 Genitourinary Cancers Symposium Merit Award from Conquer Cancer, the ASCO Foundation, and received the 2022 UCI School of Medicine Outstanding Fellow/Resident Research Award for excellence in clinical/translational research. Dr. Benjamin is a member of the American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO). Dr. Benjamin attended Tulane University School of Medicine in New Orleans, followed by an internal medicine internship and residency at University of California, Davis Medical Center in Sacramento. He completed his fellowship training in hematology/ oncology at University of California, Irvine Medical Center, where he also served as chief fellow. In his spare time, Dr. Benjamin enjoys running, watching sports (basketball and football) and traveling.

Chaitali Nangia, M.D., attended Lady Hardinge Medical College in New Delhi, India followed by a residency at Rush/Resurrection Westlake Hospital in Melrose Park, Illinois. She completed her fellowship in Hematology/Oncology at Josephine Ford Cancer Center at Henry Ford Hospital in Detroit, Michigan. Dr. Nangia then joined University of California Irvine as an associate professor in the Hematology/Oncology Division and associate program director of the Hematology/Oncology Fellowship program. Before joining Hoag, Dr. Nangia last spent her time as medical director at the Chan Soon Shiong Institute for Medicine where she ran several phase 1 clinical trials. Dr. Nangia is board certified in Hematology/Oncology and Internal Medicine.Dr. Nangia has a particular interest in breast cancer, as well as head and neck cancers.She has received several awards and honors throughout her career including being named Teacher of the Year for three years consecutively for the UCI Hematology/Oncology Division. Dr. Nangia has held professorships at University of California at Irvine, Michigan State University and Henry Ford Macomb Hospital in Warren, Michigan among others.She has more than two decades of research experience, serving as the primary investigator on several clinical research trials. Dr. Nangia has co-authored numerous peer-reviewed publications and abstracts and given clinical presentations throughout the U.S. and abroad. Dr. Nangia has joined Hoag to initiate a cellular therapy program, bringing solid tumor NK cell therapy to Orange County patients.She is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Southwest Oncology Group (SWOG) and the American Association of Physicians of Indian Origin (AAPIO).